Ribomic, Inc. (4591) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Wakamoto Pharmaceutical Co., Ltd.

Kainos Laboratories, Inc.

Perseus Proteomics, Inc.

Solasia Pharma KK

Ribomic, Inc.

Nippon Chemiphar Co., Ltd.

Pharmarise Holdings Corp.

Kubota Pharmaceutical Holdings Co. Ltd.

Renascience, Inc.

D. Western Therapeutics Institute, Inc.

Delta-Fly Pharma, Inc.

Why is Ribomic, Inc. ?

Poor Management Efficiency with a low ROE of 0%

The company has reported losses. Due to this company has reported negative ROE

Poor long term growth as Operating profit has grown by an annual rate 0.63% of over the last 5 years

Flat results in Mar 26

ROCE(HY) Lowest at -38.93%
CASH AND EQV(HY) Lowest at JPY 6,027.44 MM
OPERATING PROFIT(Q) Lowest at JPY -418.01 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -42.16%, its profits have fallen by -14%

Below par performance in long term as well as near term

Along with generating -42.16% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Ribomic, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Ribomic, Inc.

-42.16%

-0.67

52.77%

Japan Nikkei 225

85.83%

3.09

27.80%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-63.85%

EBIT Growth (5y)

0.63%

EBIT to Interest (avg)

-1,286.40

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.00

Sales to Capital Employed (avg)

0.00

Tax Ratio

0.11%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.60

EV to EBIT

-1.85

EV to EBITDA

-1.85

EV to Capital Employed

85.55

EV to Sales

1961.34

PEG Ratio

Dividend Yield

ROCE (Latest)

-4636.31%

ROE (Latest)

-32.59%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

NET PROFIT(HY)

Higher at JPY -625.61 MM

RAW MATERIAL COST(Y)

Fallen by -5,884% (YoY

NET SALES(9M)

Higher at JPY 3 MM

-9What is not working for the Company

ROCE(HY)

Lowest at -38.93%

CASH AND EQV(HY)

Lowest at JPY 6,027.44 MM

OPERATING PROFIT(Q)

Lowest at JPY -418.01 MM

PRE-TAX PROFIT(Q)

Lowest at JPY -376.19 MM

NET PROFIT(Q)

Lowest at JPY -376.49 MM

EPS(Q)

Lowest at JPY -7.04

Here's what is working for Ribomic, Inc.

Net Sales

At JPY 3 MM has Grown at 394.23%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (JPY MM)

Net Sales

Higher at JPY 3 MM

than preceding 12 month period ended Mar 2026

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Sales (JPY MM)

Raw Material Cost

Fallen by -5,884% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Ribomic, Inc.

Operating Profit

Lowest at JPY -418.01 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (JPY MM)

Pre-Tax Profit

Lowest at JPY -376.19 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Pre-Tax Profit

Fallen at -36.55%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit

Lowest at JPY -376.49 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (JPY MM)

Net Profit

Fallen at -36.41%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (JPY MM)

EPS

Lowest at JPY -7.04

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (JPY)

Cash and Eqv

Lowest at JPY 6,027.44 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents